Barclays and ABN Amro Agree to $91bln Merger

Stocks are virtually unchanged in early trading, despite some
positive earnings news and M&A activity in Europe. Barclays
(
BCS |
Quote |
Chart |
News |
PowerRating)
and
ABN Amro
(
ABN |
Quote |
Chart |
News |
PowerRating)
agreed to merge in a $91bln. deal. As part of the
deal, ABN Amro is selling LaSalle to Bank of America
(
BAC |
Quote |
Chart |
News |
PowerRating)
for
$21bln.

Staying in Europe, AstraZeneca
(
AZN |
Quote |
Chart |
News |
PowerRating)
agreed to buy MedImmune
(
MEDI |
Quote |
Chart |
News |
PowerRating)

for $15.6bln.

Among today’s stocks to watch, Hasbro
(
HAS |
Quote |
Chart |
News |
PowerRating)
, Kimberly-Clark
(
KMB |
Quote |
Chart |
News |
PowerRating)
,
and L-3 Communications
(
LLL |
Quote |
Chart |
News |
PowerRating)
all reported positive earnings. While
Delta Airlines

(
DAL |
Quote |
Chart |
News |
PowerRating)
reported a Q1 loss of $130m, compared to $2.01bln.
in the same period last year.

For more stocks to watch, see

TradingMarkets 7 Trading Ideas for Today
.

Monday’s

PowerRatings Heat Map
is displaying more red than green, a sign of potential
weakness. The Drugs sector has the highest concentration of green, but it is
also among the sectors with the most red. This dichotomy suggests traders should
look to play individual stocks rather than whole sectors.

PowerRating Heat Map: Drugs

Overall, there are only twelve stocks with
PowerRatings of 9, and no 10’s today. Our featured list shows the

Top 10 Most Requested PowerRatings
for the past 24 hours.

Top 10 Most Requested PowerRatings

For a free PowerRatings trial,
click here. If
you have any questions about PowerRatings or the new Stock Indicators please
feel free to email us or call 213-955-5858 ext 1.

Ashton Dorkins

Editor-in-Chief

editor@tradingmarkets.com

Reminder: We are in no
way recommending the purchase or short sale of these stocks. This article is
intended for education purposes only. Trading should be based on your own
understanding of market conditions, price patterns and risk; our information is
designed to contribute to your understanding.